Revolutionizing Sustainable Proteins: Onego Bio Raises $69M in Funding Round

Onego Bio, a pioneering US-Finnish food-biotech company, has successfully raised an impressive $69 million in its latest funding round, underscoring the growing demand for sustainable food solutions. Focused on revolutionizing the food system, Onego Bio utilizes cutting-edge precision fermentation technology to produce Bioalbumen®—an innovative, animal-free egg protein that mirrors the taste, nutrition, and functional properties of traditional eggs, while boasting an environmental footprint that is over 90% smaller. This groundbreaking approach not only addresses ethical concerns associated with animal agriculture but also offers a stable and sustainable ingredient that meets the escalating needs of the food industry. The recent funding will bolster Onego Bio's capabilities in scaling up production and expanding its reach within the market, allowing the company to further refine its technology and make Bioalbumen® available to a wider consumer base. As a testament to its impact in the sector, Onego was recognized as a winner of Fast Company’s 2023 World Changing Ideas awards and is actively involved in shaping industry standards as a co-founder of two key associations: the Precision Fermentation Alliance and Food Fermentation Europe. With this substantial investment, Onego Bio is poised to solidify its position as a game-changer in the protein landscape, inspiring a more sustainable future for food production and consumption.